Skip to main content
Premium Trial:

Request an Annual Quote

Invitrogen s Reorganization Tops Most-Read GenomeWeb News Stories Last Week

NEW YORK, Dec. 12 (GenomeWeb News) - What are GenomeWeb News subscribers reading? Below are the  five most-read articles for the five-day period ended Friday, Dec. 9.

 

1. Invitrogen Reorganizes in Attempt to Better Connect With Customers (from Dec. 6)

2. Ciphergen Misled Investors, Class-Action Suit Alleges; Shares Slide 9 Percent (from Dec. 6)

3. Why One Sequencer Is Never Enough: NHGRI Official Says Demand for Varied Read Lengths May Define New Market (from Dec. 5)

4. Applied Biosystems, Qiagen Ink PCR Licensing Deal (from Dec. 5)

5. 454, WashU Pen Sequencing, Gene-Expression Alliance (from Dec. 7)

The Scan

Study Follows Consequences of Early Confirmatory Trials for Accelerated Approval Indications

Time to traditional approval or withdrawal was shorter when confirmatory trials started prior to accelerated approval, though overall regulatory outcomes remained similar, a JAMA study finds.

Sequencing Study Leads to Vaccine Target in Bacteria Behind Neonatal Meningitis

Researchers eBioMedicine track down potential vaccine targets with transposon sequencing on mutant bacteria causing neonatal meningitis in mouse models of the disease.

Multiple Myeloma Progression Influenced by Immune Microenvironment Expression

Researchers in NPJ Genomic Medicine compare RNA sequencing profiles of 102,207 individual cells in bone marrow samples from 18 individuals with rapid or non-progressing multiple myeloma.

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.